SG Americas Securities
STRO icon

SG Americas Securities’s Sutro Biopharma STRO Stock Holding History

SG Americas Securities’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,491
Closed -$55K – 3556
2025
Q1 		$55K Buy
8,491
+4,448
+110% +$70.1K ﹤0.01% 3223
2024
Q4 		$74K Buy
4,043
+577
+17% +$17.6K ﹤0.01% 2827
2024
Q3 		$120K Buy
3,466
+1,989
+135% +$78K ﹤0.01% 2919
2024
Q2 		$43K Sell
1,477
-642
-30% -$25.4K ﹤0.01% 2700
2024
Q1 		$120K Sell
2,119
-1,959
-48% -$86.5K ﹤0.01% 2413
2023
Q4 		$175K Buy
4,078
+831
+26% +$26.4K ﹤0.01% 2290
2023
Q3 		$113K Buy
+3,247
New +$141K ﹤0.01% 2711
2023
Q2 		– Sell
-2,068
Closed -$96K – 3118
2023
Q1 		$96K Buy
2,068
+167
+9% +$10.6K ﹤0.01% 2932
2022
Q4 		$154K Sell
1,901
-253
-12% -$17.6K ﹤0.01% 2413
2022
Q3 		$120K Buy
2,154
+101
+5% +$5.98K ﹤0.01% 2720
2022
Q2 		$107K Buy
+2,053
New +$115K ﹤0.01% 3091
2022
Q1 		– Sell
-1,245
Closed -$185K – 3407
2021
Q4 		$185K Sell
1,245
-1,671
-57% -$299K ﹤0.01% 2709
2021
Q3 		$551K Buy
+2,916
New +$554K ﹤0.01% 2402
2021
Q2 		– Sell
-684
Closed -$156K – 3219
2021
Q1 		$156K Buy
+684
New +$162K ﹤0.01% 2837
2019
Q4 		– Sell
-1,015
Closed -$92K – 3428
2019
Q3 		$92K Sell
1,015
-866
-46% -$87.4K ﹤0.01% 2741
2019
Q2 		$214K Sell
1,881
-757
-29% -$83.4K ﹤0.01% 2378
2019
Q1 		$300K Buy
2,638
+762
+41% +$79.3K ﹤0.01% 2267
2018
Q4 		$169K Buy
+1,876
New +$226K ﹤0.01% 2467

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

SG Americas Securities's STRO Position: Q2 2025 in Review

SG Americas Securities sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 8,491 shares — an estimated $55K sold.

SG Americas Securities first reported a position in STRO in Q4 2018 and held it in 18 quarters. The position peaked at $551K in Q3 2021. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • SG Americas Securities reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 8,491 Sutro Biopharma shares in Q2 2025, an estimated $55K.
  • SG Americas Securities first reported a position in Sutro Biopharma in Q4 2018 and held it in 18 quarters.
  • SG Americas Securities's Sutro Biopharma position peaked at $551K in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.